Results

Total Results: 2,078 records

Showing results for "drugs".

101. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Vertex Pharmaceuticals Incorporated. … Vertex Pharmaceuticals Incorporated.

102. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-crohns-disease-what-treatments-or-therapies-alone-or-in-conjunction-with-one-another-provide-the-highest-rate-of-disease-management-with-the-lowest-risk-of-long-term-complications-particularly-in-young-women
     March 10, 2009 - yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to … Any additional evidence will provide peace of mind as well as potential financial relief since the drugs … Any additional evidence will provide peace of mind as well as potential financial relief since the drugs

103. Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis – An Update of the 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/osteoporosis-bone-fracture/research-protocol
     May 14, 2010 - Controlled clinical trials that report fracture outcomes for one or more of the drugs of interest will … Articles of any study design that report on adherence/persistence for any of the drugs of interest will … In our search to identify clinical studies of drugs of interest to this review, we will use terms for … osteoporosis, osteopenia, low bone density, and the drugs listed in the key questions (as well as any … In our search for the key AE, we will use terms for the AE and each of the drugs of interest for this

104. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
     February 01, 2009 - .10 Another observational study found higher mortality in those given haloperidol vs. two atypical drugs … FDA warns antipsychotic drugs may be risky for elderly. JAMA 2005;293:2462. 3. Strong C. … Using antipsychotic agents in older patients: expert consensus panel for using antipsychotic drugs … Antipsychotic drugs: prolonged QTc Interval, Torsade de Pointes, and sudden death. … Antipsychotic drugs in dementia: what should be made of the risks? JAMA 2005;294:1963-1965.

105. Urinary-Incontinence-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
     April 01, 2012 - The absolute risk difference in continence was less than 20 percent for all drugs. … Adverse effects were common with all drugs and varied between the drugs. … Treatment discontinuation due to adverse effects of drugs is common. … Benefits and harms with drugs did not differ by individual quality criteria. … • Drugs for urgency UI demonstrated similar effectiveness.

106. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The topic, buprenorphine implant (Probuphine,™ Titan Pharmaceuticals, Inc., South San Francisco, CA

107. Treatments for Schizophrenia in Adults: A Systematic (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
     January 01, 2017 - and in 2013 for SGA versus SGA drugs. … in effects associated with individual drugs. … This analysis found that all of the drugs included were superior to placebo. … The newer drugs primarily have evidence only for symptom-based outcomes and adverse events. … • Ensure comparable dosing with the best dosing titration methods for all drugs included.

108. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - CER #51: Dietary Supplements in Adults Taking Cardiovascular Drugs Original release date: April … ................................ 5 1 Dietary Supplements in Adults Taking Cardiovascular Drugs … Comparative Effectiveness Review (CER) #51, Dietary Supplements in Adults Taking Cardiovascular Drugs … Dietary Supplements in Adults Taking Cardiovascular Drugs. … OR exp Phytotherapy/ or exp Plant Preparations/ or exp Plant Extracts/ or exp Drugs, Chinese Herbal/

109. S44 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
     October 01, 2007 - : DD trials deviated from ideal PRTs in the policymakers’ domain: the policies affected mixtures of drugs … The idea that PharmaCare should use a delayed control group to evaluate drugs and policy changes was … Duration of Delays Fortunately, the policy concerned respiratory drugs with short-term effects. … A 6-month trial would have been more problematic for drugs, such as statins, with cumulative effects … Medicare holds lottery for access to expensive drugs. Am J Health Syst Pharm. 2004;61:1632,1636.

110. Microsoft Word - ehcrr#2toCSI.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
     August 01, 2007 - mood disorders, psychotic disorders, and other psychiatric disorders), prior use of anticholinergic drugs … , and current co- medication with anticholinergic drugs. … Using antipsychotic agents in older patients: Expert Consensus Panel for Using Antipsychotic Drugs in … FDA warns antipsychotic drugs may be risky for elderly. JAMA. 2005; 293: 2462. 9 Strong C. … , current use of anticholinergic drugs, total number of medications used, hospitalization and nursing

111. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
     January 01, 2012 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Teduglutide (Gattex®, NPS Pharmaceuticals, Bedminster, NJ) is a subcutaneously administered glucagon-like … Teduglutide (Gattex®, NPS Pharmaceuticals, Bedminster, NJ) is intended to provide several critical … NPS Pharmaceuticals; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p].

112. Intermittent Inhalded Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-evidence-summary-corticosteroids-asthma.pdf
     October 01, 2017 - long-term maintenance treatment of asthma in patients 6 years and older.4 The review focuses on drugs … Drugs included in the review Class Drugs ICS Beclomethasone,a budesonide,a ciclesonide,a Flunisolide … Drugs 2009;69:137-150. PMID: 19228072. 4. Spiriva Respimat [package insert]. … Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT. 2016.

113. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For emerging pharmaceuticals or biotechnologies 23 that have not yet reached market and lack cost … information, we used as proxies novel pharmaceuticals or biotechnologies entering the market within … Covers future industry trends, key industry developments, research and development of drugs and pharmaceuticals … Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics

114. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For emerging pharmaceuticals or biotechnologies 23 that have not yet reached market and lack cost … information, we used as proxies novel pharmaceuticals or biotechnologies entering the market within … Covers future industry trends, key industry developments, research and development of drugs and pharmaceuticals … Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics

115. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative or … Peripheral and Central Nervous System Drugs Advisory Committee.

116. Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
     July 01, 2014 - benzodiazepines), and drugs for insomnia? … Interventions Interventions include commonly used antidepressant drugs listed in Table A. … • The drugs in Table A compared with each other • Any nonpharmacological treatment. … searches (3,405 citations), manual searches (53 citations), and scientific information packets (Forest Pharmaceuticals … , Inc.; Jazz Pharmaceuticals; and Sanofi Aventis, U.S.), we identified a total of 3,458 potentially

117. Urinary-Incontinence-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
     October 29, 2012 - How do combined modalities of nonpharmacological treatments with drugs affect incontinence, UI severity … * p<0.05; **p<0.001; ***p<0.01 No Signal Anticholinergic drugs vs. onabotulinumtoxinA … The absolute risk difference in continence was less than 20 percent for all drugs. … The absolute risk difference in continence was less than 20 percent for all drugs. … The numbers needed to treat (NNT) to achieve continence in one woman were similar across drugs.

118. Preventive Pharmacological Treatments for Migraine in Adults and Children | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/migraine-prevention/overview
     June 03, 2013 - Archived June 3, 2013 This topic focuses on the comparative effectiveness and safety of the drugs

119. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cer-215-depression-older-adults-executive-summary.pdf
     March 01, 2019 - This review focuses on patients and drugs as classified in Table A and Figure A. … The drugs selected for inclusion were therapies that were considered most likely to be used in this … Included pharmacologic treatments for major depressive disorder in older adults Class Drugs SSRI … Although we aimed to evaluate SSRIs and SNRIs on a class basis, data for few individual drugs within … Takeda Pharmaceuticals America, Inc. Deerfield, IL. May 2018. 30.

120. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
     March 01, 2019 - This review focuses on patients and drugs as classified in Table A and Figure A. … The drugs selected for inclusion were therapies that were considered most likely to be used in this … Included pharmacologic treatments for major depressive disorder in older adults Class Drugs SSRI … Although we aimed to evaluate SSRIs and SNRIs on a class basis, data for few individual drugs within … Takeda Pharmaceuticals America, Inc. Deerfield, IL. May 2018. 30.